DL-苏式-利他林酸内酰胺 | 54593-31-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: DL-苏式-利他林酸内酰胺
• 英文名称: (6-Oxopiperidin-2-yl)(phenyl)acetic acid
• 英文别名: 2-(6-oxopiperidin-2-yl)-2-phenylacetic acid
• CAS: 54593-31-6
• 化学式: C₁₃H₁₅NO₃
• 分子量: 233.26
• InChiKey: YMVXGJVBWQZTTL-UHFFFAOYSA-N

物化性质

• 沸点：
  480.0±18.0 °C(Predicted)
• 密度：
  1.233±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Use of threo-methylphenidate compounds to enhance memory
  申请人：——

  公开号：US20020103162A1

  公开（公告）日：2002-08-01

  The present invention makes available methods and reagents for facilitating memory, e.g., to increase memory function such as long-term memory and recall ability.

  本发明提供了促进记忆的方法和试剂，例如，增加记忆功能，如长期记忆和回忆能力。
• Use of methylphenidate compounds to enhance memory
  申请人：——

  公开号：US20020132793A1

  公开（公告）日：2002-09-19

  The present invention makes available methods and reagents for facilitating memory, e.g., to increase memory function such as long-term memory and recall ability. Memory is increased by increasing attention and long term consolidation.

  本发明提供了促进记忆的方法和试剂，例如，增加记忆功能，如长期记忆和回忆能力。通过提高注意力和长期巩固来增强记忆力。
• USE OF THREO-METHYLPHENIDATE COMPOUNDS TO ENHANCE MEMORY
  申请人：Sention, Inc.

  公开号：EP1315495A2

  公开（公告）日：2003-06-04
• Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson's disease
  申请人：Fleckenstein E Annette

  公开号：US20060241082A1

  公开（公告）日：2006-10-26

  Disclosed are compositions and methods for treating Parkinson's disease.
• [EN] USE OF METHYLPHENIDATE COMPOUNDS TO ENHANCE MEMORY<br/>[FR] UTILISATION DE COMPOSES DE METHYLPHENIDATE POUR RENFORCER LA MEMOIRE
  申请人：SENTION INC

  公开号：WO2002017920A2

  公开（公告）日：2002-03-07

  The present invention discloses the use of threo-methlphenidate compounds for facilitating LTP, e.g., to increase memory function such as long-term memory and recall ability.